OptimizeRx (OPRX) Market Capitalization (2012 - 2026)

OptimizeRx has disclosed Market Capitalization across 15 years of filings, most recently posting $107.7 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 57.01% year-over-year to $107.7 million; the TTM figure through Jun 2026 stood at $107.7 million (down 57.01% YoY), while the FY2025 annual figure was $230.0 million, up 156.45% from the prior year.
• Market Capitalization came in at $107.7 million for Q2 2026 at OptimizeRx, down from $117.8 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $675.1 million in Q1 2022 to a low of $89.7 million in Q4 2024.
• Average Market Capitalization over 5 years is $253.9 million, with a median of $240.3 million recorded in 2025.
• Year-over-year, Market Capitalization plunged 82.16% in 2022 and soared 168.71% in 2025.
• Over 5 years, Market Capitalization stood at $307.2 million in 2022, then slipped by 15.43% to $259.8 million in 2023, then tumbled by 65.49% to $89.7 million in 2024, then jumped by 156.45% to $230.0 million in 2025, then slumped by 53.15% to $107.7 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $107.7 million in Q2 2026, $117.8 million in Q1 2026, and $230.0 million in Q4 2025.